Joseph Akar, MD
Cardiovascular Disease · New Haven, CTNPI 1558430058
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $57,296 of the $74,421 with a category attached, or 77.0%. Biosense Webster, Inc. accounts for 73.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $55,505 and has fallen 90.0% since, to $5,560 in 2021. Among cardiovascular disease clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $2400.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$54K
- Biotronik Inc.$10K
- Medical Device Business Services, Inc.$4K
- Sanofi-aventis U.S. LLC$3K
- AstraZeneca$2K
- Abbott$164
- plus $31 from 1 others
Across 15 payments — averaging $887.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$13K
- Boston Scientific$800
Across 1 payment — averaging $138,494 each. An ownership or investment interest held by the physician or an immediate family member.
- Pleural Dynamics Inc.$138K
What the payments were for
- Consulting fees$57,29677%
- Grants$10,00013%
- Travel & lodging$6,4149%
- Food & beverage$7111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 23 | $54,370 |
| Biotronik Inc. | 1 | $10,000 |
| Medical Device Business Services, Inc. | 3 | $4,250 |
| Sanofi-aventis U.S. LLC | 1 | $3,296 |
| AstraZeneca | 1 | $2,310 |
| Abbott | 1 | $164 |
| Medtronic | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$52,999
- Carto Smarttouch$10,260
- MULTAQ$3,296
- Carto 3$3,250
- ANDEXXA$2,310
- CartoSound$1,855
- Confirm Rx$164
How this compares
$74,421 in reported general payments places this provider in the 95th percentile of 415 cardiovascular disease providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in New Haven
- Nihar DesaiNew Haven$1.4M
- Jeffery TestaniNew Haven$546K
- Carlos Mena-HurtadoNew Haven$460K
- John ForrestNew Haven$164K
- Henry WardNew Haven$152K
- Cesia Maria Gallegos KattanNew Haven$101K
- Khurram NasirNew Haven$100K
- Tariq AhmadNew Haven$75K
- Hyung ChunNew Haven$67K
- Eric VelazquezNew Haven$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.